OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Symptomatic Treatments for the Management of Motor and Nonmotor Symptoms of Parkinson's Disease
Raquel N. Taddei, F. Spinnato, Peter Jenner
International review of neurobiology (2017), pp. 407-452
Closed Access | Times Cited: 9
Raquel N. Taddei, F. Spinnato, Peter Jenner
International review of neurobiology (2017), pp. 407-452
Closed Access | Times Cited: 9
Showing 9 citing articles:
Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson’s Disease
Nirosen Vijiaratnam, Thomas Foltynie
Drugs (2020) Vol. 80, Iss. 8, pp. 775-796
Closed Access | Times Cited: 29
Nirosen Vijiaratnam, Thomas Foltynie
Drugs (2020) Vol. 80, Iss. 8, pp. 775-796
Closed Access | Times Cited: 29
Societal Burden and Persisting Unmet Needs of Parkinson’s Disease
К. Ray Chaudhuri, Nataliya Titova
European Neurological Review (2019) Vol. 14, Iss. 1, pp. 28-28
Open Access | Times Cited: 17
К. Ray Chaudhuri, Nataliya Titova
European Neurological Review (2019) Vol. 14, Iss. 1, pp. 28-28
Open Access | Times Cited: 17
LPS induces dopamine depletion and iron accumulation in substantia nigra in rat models of Parkinson's disease.
Jie Huo, Qu Cui, Wei Yang, et al.
PubMed (2018) Vol. 11, Iss. 10, pp. 4942-4949
Closed Access | Times Cited: 8
Jie Huo, Qu Cui, Wei Yang, et al.
PubMed (2018) Vol. 11, Iss. 10, pp. 4942-4949
Closed Access | Times Cited: 8
Cn and Cn‐1B Fullerenes as Potential Nanovehicles for Piribedil Neuroprotective Drug (n=20, 36 and 60)
Miguel Reina, Christian A. Celaya, Jesús Muñiz
ChemistrySelect (2019) Vol. 4, Iss. 47, pp. 13916-13925
Closed Access | Times Cited: 4
Miguel Reina, Christian A. Celaya, Jesús Muñiz
ChemistrySelect (2019) Vol. 4, Iss. 47, pp. 13916-13925
Closed Access | Times Cited: 4
From OFF to ON—Treating OFF Episodes in Parkinson’s Disease
C. Warren Olanow, Werner Poewe, Olivier Rascol, et al.
touchREVIEWS in Neurology (2020) Vol. 16, Iss. Suppl. 1, pp. 2-2
Open Access | Times Cited: 4
C. Warren Olanow, Werner Poewe, Olivier Rascol, et al.
touchREVIEWS in Neurology (2020) Vol. 16, Iss. Suppl. 1, pp. 2-2
Open Access | Times Cited: 4
Can a cognitive rehabilitation program in early stages of Parkinson's disease improve cognition, apathy and brain functional connectivity for up to 18 months?
Antonio Daniele, Francesco Panza
European Journal of Neurology (2017) Vol. 25, Iss. 2, pp. 203-204
Closed Access | Times Cited: 3
Antonio Daniele, Francesco Panza
European Journal of Neurology (2017) Vol. 25, Iss. 2, pp. 203-204
Closed Access | Times Cited: 3
Explore the Role of the Sphingosine-1-Phosphate Signalling as a Novel Promising Therapeutic Target for the Management of Parkinson's Disease
Manoj Kumar Bisht, Jai Parkash Kadian, Tanuj Hooda, et al.
Drug Research (2024) Vol. 74, Iss. 08, pp. 365-378
Closed Access
Manoj Kumar Bisht, Jai Parkash Kadian, Tanuj Hooda, et al.
Drug Research (2024) Vol. 74, Iss. 08, pp. 365-378
Closed Access
The next chapter in symptomatic Parkinson disease treatments
Diana Hengartner, Hubert H. Fernandez
Parkinsonism & Related Disorders (2019) Vol. 59, pp. 39-48
Closed Access | Times Cited: 3
Diana Hengartner, Hubert H. Fernandez
Parkinsonism & Related Disorders (2019) Vol. 59, pp. 39-48
Closed Access | Times Cited: 3
Diseño computacional de antioxidantes multifuncionales. Caso de estudio: derivados de Edaravone
Eduardo Gabriel Guzmán López
(2019)
Open Access
Eduardo Gabriel Guzmán López
(2019)
Open Access
